Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Follow the Money: Brain-Computer Retinal Implant, Expansion of Alzheimer’s Platform, Migraine Therapies

    Mar 25, 2026, 01:00 AM by User Not Found
    Bio-IT World | Science Corporation accelerates the commercialization of their brain-computer interface retinal implant, PRIMA; Cognito Therapeutics prepares for commercial launch of their Spectris platform; Slate Medicines receives in-licensing of SLTE-1009, an anti-PACAP monoclonal antibody targeting PACAP for the prevention of migraine and other headache disorders; and more.
    Full story
  • Primerdesign Partners with Origin Sciences to Create Novel Rectal Mucosal Extraction Workflow

    Mar 24, 2026, 08:22 AM by
    Robust DNA extraction supports earlier detection and diagnosis of colorectal cancer and other gastrointestinal diseases
    Full story
  • Verily, Samsung Collaborate, Improving AI Trustworthiness, FDA Approval for PathAI

    Mar 24, 2026, 01:00 AM by User Not Found
    Bio-IT World | Verily Life Sciences and Samsung Electronics America announce a collaboration; Research Solutions launches Scite MCP; PathAI announces Breakthrough Device Designation to PathAssist Derm; and more.
    Full story
  • Abselion Appoints Dale Gordon as Chair

    Mar 23, 2026, 08:14 AM by
    Bioprocessing leader to drive continued commercial development and international expansion
    Full story
  • PerturbAI Launches with CRISPR Atlas

    Mar 20, 2026, 19:05 PM by User Not Found
    Bio-IT World | PerturbAI unveiled the world’s largest in vivo CRISPR atlas this week as it emerged from stealth. The 8 million-cell, brain-wide dataset represents the largest known causal genomics resource generated directly in living tissue.
    Full story
  • Epigenica AB Expands Presence in Japan Through Distribution Agreement with PrimeTech

    Mar 20, 2026, 08:06 AM by
    Epigenica AB today announced a distribution agreement with PrimeTech Co., Ltd., bringing Epigenica’s EpiFinder™ technologies to researchers and laboratories across the Japanese market.
    Full story
  • CellCarta Secures Global Exclusivity for Biofidelity's Aspyre® Lung to Advance Targeted Lung Cancer Testing

    Mar 20, 2026, 08:06 AM by
    CellCarta and Biofidelity today announce an expanded multi-year global strategic partnership, including exclusivity for Aspyre® Lung in clinical trial settings.
    Full story
  • ZeOmega Recognized in the 2026 Gartner® Market Guide for Intelligent Prior Authorization, U.S. Healthcare Organizations

    Mar 19, 2026, 07:45 AM by
    Full story
  • ClearNote Health Appoints Jeffrey Venstrom, MD, as Chief Medical Officer and Expands Leadership Team to Drive Clinical Adoption of Early Cancer Detection Tests

    Mar 19, 2026, 07:45 AM by
    The team at ClearNote Health strengthened its leadership team with four key additions.
    Full story
  • piRNAs Emerge as a New Frontier in Longevity

    Mar 19, 2026, 01:00 AM by User Not Found
    Bio-IT World | A new class of molecular biomarkers—piwi-interacting RNAs, or piRNAs—is emerging as researchers explore their potential not just to predict survival, but to actively modulate aging itself. In a study published in Aging Cell, a panel of five circulating piRNAs, combined with high-density lipoprotein particle counts and functional health metrics, demonstrated striking predictive power for short-term survival in older adults.
    Full story
  • QT9 Software Announces New Global Headquarters in Historic Downtown Batavia

    Mar 17, 2026, 17:37 PM by
    Adaptive reuse project will transform century-old factory into modern tech campus
    Full story
  • Lab Thread launches free version of Unified Lab Software Platform to accelerate academic research

    Mar 17, 2026, 08:24 AM by
    Silverstone, UK, 16 March 2026: Lab Thread Ltd, a UK‐based life science software company, today announced the release of a free of charge version of the Company’s Unified Lab Software Platform, available to academic and non-profit researchers worldwide. The software provides a range of core modules tailored to support early-stage research – offering an intuitive and collaborative system that enables users to quickly and easily implement robust data management plans within their own lab.
    Full story
  • Huateng Pharma to Showcase High-Purity PEG Derivatives and CDMO Services at CPHI Japan 2026

    Mar 17, 2026, 08:24 AM by
    Huateng Pharma (Hunan Huateng Pharmaceutical Co., Ltd.), a leading manufacturer of high-purity PEG derivatives, pharmaceutical intermediates and fine chemicals, today announced its participation in CPHI Japan 2026. The event will take place from April 21 to April 23 at Tokyo Big Sight.
    Full story
  • Multi-Arm PEG Architectures Expand Options for Long-Acting Biologic Development

    Mar 17, 2026, 08:24 AM by
    Biopharma PEG highlights high-purity multi-arm PEG reagents designed to support PEGylation research and therapeutic conjugation development
    Full story
  • START Partners with Trialing to Expand Access to Oncology Clinical Trials Across Europe

    Mar 17, 2026, 08:24 AM by
    This partnership will enhance physician awareness of START’s portfolio of trials, streamline referrals, and support patient access to early-phase oncology research.
    Full story
  • Open Source ‘Floats All Boats’ in AI-Driven Drug Discovery

    Mar 17, 2026, 01:26 AM by User Not Found
    Bio-IT World | More than two dozen “grand challenges” remain in small-molecule drug discovery, spanning everything from target selection to developing a medicine that can be safely used in the clinic. No single company can solve all these problems alone, which underscores the importance of computational tools, many of which are built on open-source software.
    Full story
  • Arctoris Launches Biophysics Centre of Excellence to Bridge the AI-Experimentation Gap in Drug Discovery

    Mar 16, 2026, 08:19 AM by
    Arctoris has launched a Biophysics Centre of Excellence featuring a tenfold expansion of biophysical instrumentation, including exclusive early access to the autonomous Instromeda SPRneo platform, to meet growing demand for high-quality experimental data in AI-driven drug discovery. The Centre also formalises strategic partnerships with Instromeda and SPRNexus, and welcomes internationally recognised biophysics expert Dr Iva Navratilova as Expert in Residence, establishing Arctoris as a global reference site for quantitative molecular interaction science at industrial scale.
    Full story
  • ELRIG Announces Prof Hazel Screen and Dr Dave Powell as Keynote Speakers for Advances in Cell-based Screening 2026

    Mar 12, 2026, 08:32 AM by
    • Free-to-attend conference takes place at AstraZeneca in Gothenburg, Sweden from 6–7 May • Programme to focus on advancement of animal-replacement technologies and transition towards human-first, AI-driven drug discovery
    Full story
  • DoseMe Appoints Richard Malone, PharmD, MHA, as Vice President, Clinical & Science

    Mar 12, 2026, 08:32 AM by
    DoseMe, a global leader in model-informed precision dosing (MIPD) software, today announced the appointment of Richard Malone, PharmD, MHA, as Vice President, Clinical & Science. In this role, Malone will lead the company’s clinical and scientific initiatives, including oversight of biostatistics, clinical content development, and alignment of scientific strategy with DoseMe’s broader growth objectives, including integration of newly acquired capabilities from Firstline.
    Full story
  • LabConnect Expands Global Central Laboratory Infrastructure with Wuxi, China Facility

    Mar 12, 2026, 08:32 AM by
    LabConnect has officially opened a new central laboratory facility in Wuxi, China, developed in collaboration with Teddy Laboratory (Frontage Laboratories). The site integrates into LabConnect’s global infrastructure to provide unified data, custom kit building, and biorepository services for multi-regional clinical trials. This expansion brings the company to eight global locations, supporting both multinational firms entering China and Asia-Pacific organizations expanding their research internationally.
    Full story
  • 1
  • 2 (current)
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy